Literature DB >> 12538380

Oxidative stress and gene expression in sepsis.

J Macdonald1, H F Galley, N R Webster.   

Abstract

Dysregulation of the immuno-inflammatory response, as seen in sepsis, may culminate in host cell and organ damage. Lipopolysaccharide from Gram-negative bacterial cell walls induces gene activation and subsequent inflammatory mediator expression. Gene activation is regulated by a number of transcription factors at the nuclear level, of which nuclear factor kappaB appears to have a central role. The redox (reduction-oxidation) cellular balance is important for normal cellular function, including transcription factor regulation. In sepsis, a state of severe oxidative stress is encountered, with host endogenous antioxidant defences overcome. This has implications for cellular function and the regulation of gene expression. This review gives an overview of the mechanisms by which transcription factor activation and inflammatory mediator overexpression occur in sepsis, together with the events surrounding the state of oxidative stress encountered and the effects on the host's antioxidant defences. The effect of oxidative stress on transcription factor regulation is considered, together with the role of antioxidant repletion in transcription factor activation and in sepsis in general. Other interventions that may modulate transcription factor activation are also highlighted.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12538380     DOI: 10.1093/bja/aeg034

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  97 in total

Review 1.  Mobilization in severe sepsis: an integrative review.

Authors:  Sushant Govindan; Theodore J Iwashyna; Andrew Odden; Scott A Flanders; Vineet Chopra
Journal:  J Hosp Med       Date:  2015-01       Impact factor: 2.960

2.  The effects of aging on pulmonary oxidative damage, protein nitration, and extracellular superoxide dismutase down-regulation during systemic inflammation.

Authors:  Marlene E Starr; Junji Ueda; Shoji Yamamoto; B Mark Evers; Hiroshi Saito
Journal:  Free Radic Biol Med       Date:  2010-11-17       Impact factor: 7.376

3.  Antioxidant therapy in sepsis.

Authors:  Gerd Albuszies; Uwe Bernd Brückner
Journal:  Intensive Care Med       Date:  2003-08-16       Impact factor: 17.440

4.  Pediatric Respiratory Assembly. Mini symposium on lung inflammation.

Authors:  Larry C Lands; A Keith Tanswell; Sophie Laberge; Christine McCusker; Felix Ratjen
Journal:  Can Respir J       Date:  2010 Mar-Apr       Impact factor: 2.409

Review 5.  Pharmacological targets in the renal peritubular microenvironment: implications for therapy for sepsis-induced acute kidney injury.

Authors:  Philip R Mayeux; Lee Ann MacMillan-Crow
Journal:  Pharmacol Ther       Date:  2012-01-16       Impact factor: 12.310

Review 6.  [Intensive care unit-acquired weakness in the critically ill : critical illness polyneuropathy and critical illness myopathy].

Authors:  K Judemann; D Lunz; Y A Zausig; B M Graf; W Zink
Journal:  Anaesthesist       Date:  2011-10       Impact factor: 1.041

7.  Selenium effect on oxidative stress factors in septic rats.

Authors:  Elmira Zolali; Hadi Hamishehkar; Nasrin Maleki-Dizaji; Naime Majidi Zolbanin; Hamed Ghavimi; Maryam Kouhsoltani; Parina Asgharian
Journal:  Adv Pharm Bull       Date:  2014-02-07

8.  The effect of smoking on MAOA promoter methylation in DNA prepared from lymphoblasts and whole blood.

Authors:  Robert A Philibert; Steven R H Beach; Tracy D Gunter; Gene H Brody; Anup Madan; Meg Gerrard
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-03-05       Impact factor: 3.568

9.  Effect of heme oxygenase–endogenous carbon monoxide on mortality during septic shock in rats.

Authors:  J-b Yu; S-l Yao
Journal:  Ir J Med Sci       Date:  2009-12       Impact factor: 1.568

10.  Regulation of pentraxin-3 by antioxidants.

Authors:  A L Hill; D A Lowes; N R Webster; C C Sheth; N A R Gow; H F Galley
Journal:  Br J Anaesth       Date:  2009-10-28       Impact factor: 9.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.